Retatrutide: Maintained at established dose (typically 8 to 12 mg weekly) BPC-157: 0.25 mg daily TB-500: 2.5 mg twice weekly (loading) or 2 mg weekly (maintenance) GHK-Cu: 0.1 to 0.2 mg three times weekly Duration: 8 to 12 weeks maximum, with 30-day minimum break between cycles The injection schedule for the complete GLOW protocol requires careful organization
Men Often Benefit Most When Peptides Address: Early androgen-related thinning Diminishing density at the crown or hairline Inflammatory scalp issues Follicle repair and support Men often find peptides useful even if theyre avoiding DHT blockers
In the 12 mg dose group, 16% of subjects discontinued due to adverse events (AEs), but the overall incidence of severe adverse events (SAEs) was low, about 6%-8%
Who Should Consider GHK-Cu Therapy
Pharmacol Rev 43:109142 Nordt SP, Williams SR, Turchen S, Manoguerra A, Smith D, Clark RF (1996) Hypermagnesemia following an acute ingestion of Epsom salt in a patient with normal renal function
Additionally, a pharmacy can compound medications of FDA-approved drugs that are in shortage